⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma
globenewswire.com
ABBV
ARCC
GSK
JNJ
REGN
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
globenewswire.com
LUN
LLY
AMGN
NVS
TEVA
ALLER
BHVN
DRREDDY
ABBV
IMPL
ZSAN
AXSM
AEON
IONS
CHRC
AZN
GSK
WSTN
Chronic Kidney Disease Anemia Market Opportunity Assessment and Forecasts 2024-2034: Drug Costs, Safety Improvements, ESA Alternatives, and Enhanced Clinical Trial Design
globenewswire.com
AMGN
JNJ
GSK
ABBVIE
AKORN
AVROBIO
BAYER
MERCK
COSM
ROCHE
CHMP
SHP
ASTELLAS
Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global Uptake of Next-Generation Vaccines & Monoclonal Antibodies Accelerates
prnewswire.com
PFE
GSK
AZN
SNY
MRK
MRNA
Fallopian Tube Cancer Market Analysis and Global Business Opportunities, 2025-2035 - Targeted Therapies Transform the Fallopian Tube Cancer Treatment Landscape - ResearchAndMarkets.com
businesswire.com
AZN
GSK
PFE
Navigating ICH GCP (Good Clinical Practice) E6 (R3): What You Need to Know Training Course (VIRTUAL EVENT: Jan 29, 2026) - ResearchAndMarkets.com
businesswire.com
GSK
8MM Respiratory Syncytial Virus Prophylaxis Drug Forecast Report 2025: A $7.2 Billion Market by 2030, Prophylactic Options to Continue to Diversify Due to Strength of Late-stage Pipeline
globenewswire.com
AZN
ABBV
SNY
MRK
GSK
PFE
MRNA
Inhaled Therapy in Respiratory Disease Market to Grow USD 16.22 Billion by 2034
globenewswire.com
GSK
AZN
TEVA
BMY
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
globenewswire.com
GSK
TREVI
MRK
AZN
SNY
TEVA
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL